State Street’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

State Street’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-2,177,900	Closed	-$376M	–	3859
2015 Q1	$376M	Sell	2,177,900 -9,482	-0.4%	-$1.39M	0.04%	440
2014 Q4	$251M	Buy	2,187,382 +347,935	+19%	+$42.1M	0.03%	546
2014 Q3	$287M	Sell	1,839,447 -77,271	-4%	-$11.2M	0.03%	489
2014 Q2	$236M	Buy	1,916,718 +18,309	+1%	+$2.02M	0.03%	551
2014 Q1	$197M	Sell	1,898,409 -17,092	-0.9%	-$1.75M	0.02%	591
2013 Q4	$172M	Buy	1,915,501 +24	+0%	+$1.91K	0.02%	630
2013 Q3	$128M	Buy	1,915,477 +703,034	+58%	+$48.4M	0.02%	714
2013 Q2	$80.2M	Buy	+1,212,443	New	+$69.3M	0.01%	872

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $487M AUM 49.37% 1-Year Est. Return

State Street's SLXP Position: Q2 2015 in Review

State Street sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 2,177,900 shares — an estimated $376M sold.

State Street first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $376M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

State Street reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
State Street sold 2,177,900 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $376M.
State Street first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
State Street's SALIX PHARMACEUTICALS LTD DEL position peaked at $376M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on State Street's 13F filing for Q2 2015, filed 13 Aug 2015.